Real Foodology Podcast Summary: "Former Pharma Rep Breaks Down How Your Insurance Is Overcharging You + Keeping You Sick | Brigham Buhler"

Release Date: October 29, 2024

In this enlightening episode of the Real Foodology podcast, host Courtney Swan engages in a profound conversation with Brigham Buhler, a former pharmaceutical representative turned healthcare advocate. This episode delves deep into the intricate and often obscured mechanisms by which insurance companies overcharge consumers, perpetuating a cycle of chronic illness and financial burden.

Introduction to Brigham Buhler

Courtney Swan introduces Brigham Buhler, highlighting his impactful appearance on Joe Rogan's podcast three years prior, where Brigham shed light on the corruptions within the insurance industry. Courtney expresses her enthusiasm for having Brigham on the show, recognizing the depth of knowledge he brings regarding the often invisible workings of big insurance.

The Insurance Overcharge Mechanism

Brigham elucidates how the American healthcare system is fundamentally rigged to prioritize profits over patient well-being. He explains that insurance companies, alongside pharmaceutical benefit managers (PBMs), manipulate reimbursement rates and deductibles to maximize their earnings. Brigham states:

“If you eat the average American diet and you go to the average American primary care, you can be prepared to die of the average American disease.”
[00:10]

He breaks down the complexity of deductibles, explaining how patients are often left paying exorbitant amounts out-of-pocket before insurance begins to reimburse, and even then, only partially. This system ensures that insurance companies benefit financially from ongoing chronic illnesses rather than investing in preventive care.

Pharmacy Benefit Managers (PBMs) and Gag Clauses

A significant portion of the conversation focuses on PBMs and their role in inflating medication costs. Brigham highlights how PBMs negotiate rebates with pharmaceutical companies, leading to higher listed drug prices while pocketing substantial profits. He provides a stark example:

“They say we're paying $1,500 for a GLP1, but they're actually getting a $500 rebate.”
[14:07]

Brigham also exposes the existence of gag clauses that prevent pharmacies from informing patients about cheaper cash prices for medications. This practice forces patients to pay inflated prices without the option of knowing about more affordable alternatives.

Impact on Patients

The ramifications of these practices on patients are severe. Brigham shares poignant anecdotes of individuals receiving massive medical bills for minor procedures and the consequent anxiety and financial strain. He explains how insurance companies manipulate deductible structures to exhaust coverage rapidly, leaving patients financially vulnerable:

“Insurance wants you to meet your deductible quickly so they can pass the remaining costs back to you.”
[58:32]

This manipulation discourages individuals from seeking necessary medical care due to the fear of unaffordable bills, exacerbating public health issues.

Corporate Capture of Healthcare

Brigham discusses the broader issue of corporate capture within the healthcare system. He traces the evolution of major insurance companies acquiring PBMs, thereby consolidating control over medication pricing and distribution. This consolidation ensures that insurance companies maintain a stranglehold on healthcare costs, prioritizing shareholder profits over patient care.

Regulatory Failures and Medical Device Concerns

The episode also touches upon the failures of regulatory bodies like the FDA. Brigham criticizes the 510(k) approval process, which allows medical devices to enter the market without rigorous human safety studies. He recounts alarming instances of medical devices causing severe health issues, underscoring the lack of stringent oversight:

“Over 90% of medical devices in operating rooms haven’t been tested on humans.”
[38:43]

Solutions and Alternatives: Wastwell’s Preventive Approach

Transitioning from critique to solutions, Brigham introduces his company, Wastwell, which focuses on preventive and predictive healthcare. By leveraging telemedicine and AI-driven tools, Wastwell aims to provide comprehensive blood work and personalized health plans outside the traditional insurance framework. This approach empowers individuals to take control of their health without the financial and bureaucratic constraints imposed by insurance companies.

Brigham emphasizes the importance of proactive health management:

“We focus on longevity and preventative care because that’s what insurance companies refuse to cover.”
[65:06]

Optimism and the Path Forward

Despite the daunting challenges, both Courtney and Brigham express optimism about the future of healthcare. They discuss emerging technologies, such as AI and advanced screening tools, that hold promise in making preventive care more accessible and affordable. Brigham highlights the potential of AI to reduce costs and improve personalized care, envisioning a future where individuals have greater autonomy over their health decisions.

Brigham concludes with an inspiring message:

“We’re going to drive down the cost of healthcare and make this affordable for everybody.”
[89:50]

Closing Thoughts

The episode wraps up with a call to action for listeners to take ownership of their health and seek out preventive care options outside the traditional insurance system. Courtney and Brigham stress the importance of informed decision-making and the adoption of healthier lifestyles to combat the systemic issues perpetuating chronic diseases.

Key Takeaways:

• Insurance System Flaws: Insurance companies and PBMs collaborate to inflate drug prices and prioritize profits over patient health, creating significant financial and health burdens for individuals.

• Gag Clauses: Pharmacies are legally restricted from informing patients about cheaper cash alternatives for medications, further entrenching high costs.

• Corporate Control: Major insurance companies' acquisition of PBMs centralizes control over healthcare pricing and access, limiting patient choices and increasing costs.

• Regulatory Shortcomings: The FDA’s lax approval processes for medical devices contribute to widespread health risks and insufficient patient protection.

• Preventive Solutions: Companies like Wastwell offer alternative healthcare models focused on preventive medicine, utilizing telemedicine and AI to provide affordable, personalized care.

• Future Optimism: Technological advancements and proactive health management hold promise for transforming the healthcare landscape, making preventive care more accessible and reducing overall healthcare costs.

This episode serves as a critical exposé on the hidden mechanisms that keep Americans overcharged and underinsured, while also providing hope through innovative solutions aimed at reclaiming individual health sovereignty.

Notable Quotes:

• “If you eat the average American diet and you go to the average American primary care, you can be prepared to die of the average American disease.”
  – Brigham Buhler, [00:10]

• “They say we're paying $1,500 for a GLP1, but they're actually getting a $500 rebate.”
  – Brigham Buhler, [14:07]

• “Insurance wants you to meet your deductible quickly so they can pass the remaining costs back to you.”
  – Brigham Buhler, [58:32]

• “We focus on longevity and preventative care because that’s what insurance companies refuse to cover.”
  – Brigham Buhler, [65:06]

• “We’re going to drive down the cost of healthcare and make this affordable for everybody.”
  – Brigham Buhler, [89:50]

Where to Find More Information

For more insights and actionable strategies to take control of your health, visit Wastwell at wastwell.com and follow Brigham Buhler on Instagram @realfoodology.